{
    "2020-05-29": [
        [
            {
                "time": "2023-03-15",
                "original_text": "FDA Okays Lilly's Alzheimer's Disease Diagnostic Agent Tauvid",
                "features": {
                    "keywords": [
                        "FDA",
                        "Lilly",
                        "Alzheimer's",
                        "Tauvid",
                        "diagnostic"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Lilly Cleared by FDA to Market Alzheimer's Detection Drug",
                "features": {
                    "keywords": [
                        "Lilly",
                        "FDA",
                        "market",
                        "Alzheimer's",
                        "detection"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Pharma Stock Roundup: MRK, RHHBY Give Coronavirus Updates, SNY to Sell Stake in REGN",
                "features": {
                    "keywords": [
                        "Pharma",
                        "MRK",
                        "RHHBY",
                        "SNY",
                        "REGN",
                        "Coronavirus"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Veeva Systems (VEEV) Q1 Earnings and Revenues Beat Estimates",
                "features": {
                    "keywords": [
                        "Veeva",
                        "Systems",
                        "Q1",
                        "earnings",
                        "revenues",
                        "beat",
                        "estimates"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "software"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Lilly gets FDA approval for Alzheimer's diagnostic agent",
                "features": {
                    "keywords": [
                        "Lilly",
                        "FDA",
                        "approval",
                        "Alzheimer's",
                        "diagnostic"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Eli Lilly Earns Landmark Approval for Alzheimer's Disease Imaging Agent",
                "features": {
                    "keywords": [
                        "Eli",
                        "Lilly",
                        "Landmark",
                        "Approval",
                        "Alzheimer's",
                        "Imaging"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}